SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-22-006641
Filing Date
2022-09-13
Accepted
2022-09-13 20:45:40
Documents
2
Period of Report
2021-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3/A  
1 PRIMARY DOCUMENT primarydocument.xml 3/A 4883
2 POWER OF ATTORNEY- SMITH smithex24.txt EX-24 3533
  Complete submission text file 0001562180-22-006641.txt   9829
Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
SMITH IAN F (Reporting) CIK: 0001197032 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39634 | Film No.: 221241891

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences